Serum galectin-3 in chronic kidney disease: association with disease stage and value after kidney transplantation
Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế · 17.05.2026 · 18 (3)
DOI: 10.38103/jcmhch.18.3.7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế, online erschienen am 17.05.2026. Verfasst von Dinh Thi Minh Hao und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Serum creatinine is a traditional marker in chronic kidney disease, which is valuable in monitoring renal function and prognosis after kidney transplantation. Recently, several novel biomarkers have been introduced to diagnose and predict chronic kidney disease as well as monitor kidney transplant function. Galectin-3 is one such marker. Increased galectin-3 concentration has been reported to be associated with renal fibrosis. High serum galectin-3 concentration is also associated with the risk of rapid renal function decline, new chronic kidney disease and progressive renal failure, as well as predicting events and mortality in patients with renal impairment.
Methods
A cross-sectional analytical study was conducted at Hue Central Hospital from October 2024 to October 2025. Patients with CKD stages 3-5, patients receiving maintenance hemodialysis, and stable kidney transplant recipients at 3 months post-transplantation were enrolled. Serum galectin-3 concentrations were measured using chemiluminescent microparticle immunoassay on the Abbott Alinity platform at Biochemistry Department - Hue Central Hospital.
Results
A total of 172 pre-transplant CKD patients and 32 post-transplant recipients were included. Mean serum galectin-3 level in the CKD group was 53.97 ± 25.68 ng/mL and increased progressively with disease severity: stage 3 (28.87 ± 8.02), stage 4 (44.77 ± 17.07), stage 5 non-dialysis (56.69 ± 20.66), and maintenance hemodialysis (72.75 ± 24.86 ng/mL) (p < 0.001). Galectin-3 level decreased markedly after transplantation (15.25 ± 5.97 ng/mL). Serum galectin-3 was positively correlated with creatinine (r = 0.605, p < 0.001) and negatively correlated with estimated glomerular filtration rate (eGFR) (r = -0.627, p < 0.001).
Conclusion
Serum galectin-3 levels rise with CKD progression and decline significantly after kidney transplantation. Galectin-3 may serve as a useful biomarker for disease severity assessment and post-transplant monitoring.
Zitieren
APA
Hao, D. T. M., & Tam, V. (2026). Serum galectin-3 in chronic kidney disease: association with disease stage and value after kidney transplantation. Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế, 18(3). https://doi.org/10.38103/jcmhch.18.3.7
Vancouver
Hao DTM, Tam V. Serum galectin-3 in chronic kidney disease: association with disease stage and value after kidney transplantation. Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế. 2026;18(3). doi:10.38103/jcmhch.18.3.7
BibTeX
@article{Hao2026,
author = {Hao, Dinh Thi Minh and Tam, Vo},
title = {Serum galectin-3 in chronic kidney disease: association with disease stage and value after kidney transplantation},
journal = {Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế},
year = {2026},
volume = {18},
number = {3},
doi = {10.38103/jcmhch.18.3.7}
}
EUVIMED